DE69403197D1 - Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind - Google Patents

Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind

Info

Publication number
DE69403197D1
DE69403197D1 DE69403197T DE69403197T DE69403197D1 DE 69403197 D1 DE69403197 D1 DE 69403197D1 DE 69403197 T DE69403197 T DE 69403197T DE 69403197 T DE69403197 T DE 69403197T DE 69403197 D1 DE69403197 D1 DE 69403197D1
Authority
DE
Germany
Prior art keywords
helminth
loss
natural immunity
controlling
diseases associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69403197T
Other languages
English (en)
Other versions
DE69403197T2 (de
Inventor
Timothy Peter Mallinckro Rolph
Stuart John Mallinckro Andrews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet Inc
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of DE69403197D1 publication Critical patent/DE69403197D1/de
Publication of DE69403197T2 publication Critical patent/DE69403197T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0003Invertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69403197T 1993-02-24 1994-02-23 Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind Expired - Fee Related DE69403197T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939303681A GB9303681D0 (en) 1993-02-24 1993-02-24 Vaccines
PCT/GB1994/000354 WO1994019010A1 (en) 1993-02-24 1994-02-23 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity

Publications (2)

Publication Number Publication Date
DE69403197D1 true DE69403197D1 (de) 1997-06-19
DE69403197T2 DE69403197T2 (de) 1997-08-28

Family

ID=10730938

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69403197T Expired - Fee Related DE69403197T2 (de) 1993-02-24 1994-02-23 Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind

Country Status (17)

Country Link
EP (1) EP0686041B1 (de)
JP (1) JPH08506828A (de)
AT (1) ATE152916T1 (de)
AU (1) AU679494B2 (de)
BG (1) BG61934B1 (de)
CA (1) CA2155119A1 (de)
CZ (1) CZ213895A3 (de)
DE (1) DE69403197T2 (de)
ES (1) ES2102836T3 (de)
GB (1) GB9303681D0 (de)
HU (1) HUT72919A (de)
MX (1) MX9401384A (de)
NO (1) NO953311L (de)
NZ (1) NZ261598A (de)
RU (1) RU2145876C1 (de)
WO (1) WO1994019010A1 (de)
ZA (1) ZA941237B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815674D0 (en) * 2008-08-28 2008-10-08 Moredun Res Inst Nematode vaccine
EP4054719A1 (de) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras-inhibitoren
WO2023114954A1 (en) 2021-12-17 2023-06-22 Genzyme Corporation Pyrazolopyrazine compounds as shp2 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
ZW8893A1 (en) * 1992-07-21 1994-06-01 Pitman Moore Inc Vaccines

Also Published As

Publication number Publication date
BG99888A (bg) 1996-04-30
GB9303681D0 (en) 1993-04-14
WO1994019010A1 (en) 1994-09-01
NZ261598A (en) 1997-03-24
NO953311D0 (no) 1995-08-23
DE69403197T2 (de) 1997-08-28
JPH08506828A (ja) 1996-07-23
CZ213895A3 (en) 1996-03-13
ES2102836T3 (es) 1997-08-01
NO953311L (no) 1995-10-19
EP0686041A1 (de) 1995-12-13
HUT72919A (en) 1996-06-28
AU6041594A (en) 1994-09-14
MX9401384A (es) 1994-08-31
BG61934B1 (bg) 1998-10-30
AU679494B2 (en) 1997-07-03
HU9502467D0 (en) 1995-10-30
ZA941237B (en) 1994-09-19
EP0686041B1 (de) 1997-05-14
RU2145876C1 (ru) 2000-02-27
ATE152916T1 (de) 1997-05-15
CA2155119A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
DE69431404D1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
DE69431358D1 (de) Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
DE69533964D1 (de) Orale immunisierung durch verwendung von transgenen pflanzen
ATE127345T1 (de) Stressproteine und verwendungen dafür.
ATE268353T1 (de) Verfahren zur herstellung von mit antioxidant gedoptem uhmwpe und daraus hergestelltes implantat
DE58906718D1 (de) Kunststeine, verfahren zur herstellung und verwendung derselben.
DK511381A (da) Mucopolysaccaharider som har biologiske egenskaber deres fremstilling og deres anvendelse som laegemidler
NO923953D0 (no) Peptider
ATE348633T1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
EA199900069A1 (ru) Вакцинная композиция против малярии
GB9209993D0 (en) Vaccines
DE3779281D1 (de) Duenner moertel zur bodeneinspritzung und methode zur anwendung.
ES2089923T3 (es) Composicion de vacuna subunitaria recombinante viva y procedimiento de preparacion.
DE69403197D1 (de) Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind
ES2177535T3 (es) Vacunas contra protozoos intestinales.
ATE424217T1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ATE134878T1 (de) Impfstoffe gegen metazoen-parasiten
ATE509104T1 (de) Verfahren zur herstellung von mikroverkapselter dna zur impfung und gentherapie
ES2091159A1 (es) Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
BR9711138A (pt) Prepara-{es de herperv¡rus equino com prote-Æo mÚtua e m-todo de fazer e usar as mesmas
ATA142391A (de) Verwendung von emulsionen des typs oel-in-wasser, sowie verfahren zur herstellung von betonsteinen mit besonderen eigenschaften
GR3021983T3 (en) Cross-reactive influenza a immunization
DE3770586D1 (de) Optische reflektoren, herstellungsverfahren und plastikzusammensetzung zur anwendung des verfahrens.
ATA123079A (de) Formstein, insbesondere schalungsformstein, formsteinsatz mit solchen formsteinen sowie formling zur herstellung solcher formsteine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8327 Change in the person/name/address of the patent owner

Owner name: SCHERING PLOUGH ANIMAL HEALTH CORP., UNION, N.J.,